IPF patients: is combining drugs better than switching?
NCT ID NCT03939520
First seen Feb 17, 2026 · Last updated May 22, 2026 · Updated 16 times
Summary
This study looked at 279 people with idiopathic pulmonary fibrosis (IPF) whose disease was getting worse despite taking one of two approved drugs (pirfenidone or nintedanib). The goal was to see if combining both drugs works better than switching to the other drug alone. The trial measured lung function decline and how well patients tolerated the treatments over time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROGRESSIVE IDIOPATHIC PULMONARY FIBROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
AP - HP - Hôpital Avicenne
Bobigny, France
-
APHP - Hôpital Xavier Bichat-Claude Bernard
Paris, France
-
CHRU Hôpital Cavale Blanche
Brest, France
-
CHRU de Besançon - Hôpital Jean Minjoz
Besançon, France
-
CHRU de Lille - Hôpital Albert Calmette
Lille, France
-
CHRU de Montpellier - Hôpital Arnaud de Villeneuve
Montpellier, France
-
CHRU, Tours - Hôpital Bretonneau
Tours, France
-
CHU - Hôpital G.R. Laennec
Nantes, France
-
CHU Dijon Bourgogne - Hôpital François Mitterrand
Dijon, France
-
CHU Nancy - Hôpital Brabois
Vandœuvre-lès-Nancy, France
-
CHU Poitiers
Poitiers, 86021, France
-
CHU Rennes - Hôpital Pontchaillou
Rennes, France
-
CHU d'Angers
Angers, France
-
CHU de Caen - Hôpital de la Côte de Nacre
Caen, France
-
CHU de Marseille - Hôpital Nord
Marseille, France
-
CHU de Nice, Hôpital Pasteur
Nice, France
-
CHU de Toulouse - Hôpital Larrey
Toulouse, France
-
Centre Hospitalier de la côte Basque
Bayonne, France
-
Ch de Cornouaille
Quimper, France
-
Groupe Hospitalier Paris Saint Joseph
Paris, France
-
Hôpital Pneumologique et Cardiovasculaire Louis Pradel
Bron, France
-
Hôpital Robert Schuman
Vantoux, France
Conditions
Explore the condition pages connected to this study.